HOXA9 and cancer: Despite missense mutations frequently occurring SNVs in almost all cancer types, the overall mutation rate across cancers was only 32% (Fig. 4A, B), indicating that other factors might regulate the expression of HOXA9. Subsequently, we checked whether the upregulation of HOXA9 in 9 TCGA cancer types was attributed to CNVs at this locus.